Edward McKenna

Edward McKenna

UNVERIFIED PROFILE

Are you Edward McKenna?   Register this Author

Register author
Edward McKenna

Edward McKenna

Publications by authors named "Edward McKenna"

Are you Edward McKenna?   Register this Author

21Publications

1671Reads

9Profile Views

Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 08 6;25(8):1689-1694. Epub 2019 Apr 6.

Blood & Marrow Transplantation and Cellular Therapy Program, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.04.003DOI Listing
August 2019

mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study.

Onco Targets Ther 2017 17;10:965-971. Epub 2017 Feb 17.

Melanoma Section, Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S120440DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322838PMC
February 2017

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.

J Am Acad Dermatol 2014 Jan 1;70(1):60-9. Epub 2013 Nov 1.

Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, Scottsdale, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.09.012DOI Listing
January 2014

Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.

Breast Cancer Res Treat 2012 Dec 27;136(3):777-88. Epub 2012 Oct 27.

Baylor-Charles A. Sammons Cancer Center, Texas Oncology, US Oncology, 3410 Worth Street, Suite 400, Dallas, TX 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2288-xDOI Listing
December 2012

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab.

Breast Cancer Res Treat 2012 Apr 4;132(3):781-91. Epub 2011 Mar 4.

Division of Hematology/Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Leonard M. Miller School of Medicine, 1475 NW 12th Ave., Suite 3510, Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1412-7DOI Listing
April 2012

Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials.

Breast Cancer Res Treat 2011 Jan 3;125(2):431-9. Epub 2010 Nov 3.

Baylor-Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX, 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1222-3DOI Listing
January 2011

XeNA: capecitabine plus docetaxel, with or without trastuzumab, as preoperative therapy for early breast cancer.

Int J Med Sci 2008 4;5(6):341-6. Epub 2008 Nov 4.

Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581822PMC
http://dx.doi.org/10.7150/ijms.5.341DOI Listing
February 2009

Defining the molecular components of calcium transport regulation in a reconstituted membrane system.

Biochemistry 2003 Apr;42(15):4585-92

Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi026995aDOI Listing
April 2003